This article is more than 5 years old. Information may no longer be current.

CCT in AMD patients similar to control group, study finds

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Central corneal thickness in patients with neovascular age-related macular degeneration does not differ from that of healthy controls, according to a study by researchers in Greece.

George D. Kymionis, MD, PhD, of the University of Crete, and colleagues measured central cornea thickness (CCT) in 130 eyes of 130 AMD patients and 98 eyes of 98 age-, sex- and axial length-matched controls.

The researchers found mean CCT in the AMD group was 549.44 µm. It was not significantly different from a mean CCT of 544.35 µm in the control group (P = .11), according to the study.

The study is published in the February issue of Cornea.